Higher prices for the many products that contain chips threaten to hit demand.

The FDA has approved an investigational device exemption (IDE) application for the start of a pilot study evaluating the Alpha diffusing alpha-emitters radiation therapy (DaRT) technology in patients ...

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

Medical announced that the FDA has approved an Investigational Device Exemption, IDE, application to initiate a pilot study ...

Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, ...

Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...

JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study ...

Full REMAIN-1 pivotal study enrollment anticipated in summer 2025 ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, ...

Abbott is officially bringing the noise—literally—by launching a clinical trial for its new intravascular lithotripsy (IVL) ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...